April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Dystrophin-Dp71-null mouse presents retinal vascular inflammation
Author Affiliations & Notes
  • Brahim El Mathari
    Therapeutic, Institut de la Vision/INSERM/UPMC Univ Paris 06/CNRS/CHNO des Quinze-Vingts, Paris, France
    Sanofi-Fovea, Institut de la vision, Paris, France
  • Hugo Charles-Messance
    Therapeutic, Institut de la Vision/INSERM/UPMC Univ Paris 06/CNRS/CHNO des Quinze-Vingts, Paris, France
  • Claudine Grepin
    Sanofi-Fovea, Institut de la vision, Paris, France
  • Michel J Roux
    Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR_7104, Inserm U 964, Université de Strasbourg, Strasbourg, France
  • Jose Alain Sahel
    Therapeutic, Institut de la Vision/INSERM/UPMC Univ Paris 06/CNRS/CHNO des Quinze-Vingts, Paris, France
    Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
  • Ramin Tadayoni
    Therapeutic, Institut de la Vision/INSERM/UPMC Univ Paris 06/CNRS/CHNO des Quinze-Vingts, Paris, France
    Ophthalmology Dept, Hôpital Lariboisière, AP-HP, Univ Paris Diderot, Paris, France
  • Alvaro Rendon
    Therapeutic, Institut de la Vision/INSERM/UPMC Univ Paris 06/CNRS/CHNO des Quinze-Vingts, Paris, France
  • Footnotes
    Commercial Relationships Brahim El Mathari, Sanofi-Fovea (E); Hugo Charles-Messance, None; Claudine Grepin, Sanofi-Fovea (E); Michel Roux, None; Jose Sahel, None; Ramin Tadayoni, None; Alvaro Rendon, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5819. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brahim El Mathari, Hugo Charles-Messance, Claudine Grepin, Michel J Roux, Jose Alain Sahel, Ramin Tadayoni, Alvaro Rendon; Dystrophin-Dp71-null mouse presents retinal vascular inflammation. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5819.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Dystrophin Dp71 is a cytoskeleton membrane associated protein, which is expressed in Müller cells and astrocytes. These two cell types contact and ensheath the retinal vascular plexus. The perivascular localization of Dp71 protein is fundamental for blood-retinal barrier (BRB) stabilization. Indeed, we have shown that the deletion of Dp71 induces a highly permeable BRB (Sene, 2009). Given that BRB breakdown is involved in retinal inflammation, here we undertook to investigate if the absence of Dp71 brings out retinal vascular inflammation?

Methods: The expression of VEGFa, ICAM-1 and CD11b was quantified by qPCR, ELISA and immunohistochemistry methods. Retinal leukostasis in mice was assessed after perfusion with FITC-conjugated concanavalin A.

Results: VEGFa is overexpressed in DR and binds to VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1). VEGFa mRNA and protein were overexpressed in the retina of KoDp71 mice compared to the wildtype. VEGFR-1 was also overexpressed. ICAM-1 is expressed on endothelial cells surface to recruits leukocytes. CD11b is expressed on the surface of leukocytes to bind ICAM-1. The expression of ICAM-1 and CD11b was increased in absence of Dp71 protein. Leukostasis which is a hallmark of inflammation was increased in KoDp71 mice.

Conclusions: The deletion of Dp71 protein induces retinal inflammation with overexpression of VEGFa, ICAM-1 and CD11b, leukostasis and breakdown of the blood-retinal barrier which are characteristic of retinal inflammation. All together these results suggest that the Dp71-null mouse could be a good model to study retinal vascular diseases like diabetic retinopathy.

Keywords: 557 inflammation • 748 vascular endothelial growth factor • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×